News | December 04, 2025
Philips unveils helium-free 3.0T MRI innovation at RSNA 2025
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo and Evfraxy) in Europe starting December 2, 2025
FDA's withholding of the PRV was contrary to law because no drug product containing phenobarbital sodium was 'previously approved'
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
Subscribe To Our Newsletter & Stay Updated
